Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An intravitreal cannula system: long-term follow-up study.

T Ishibashi, K Miki, R Patterson

    International Ophthalmology
    |April 1, 1986
    PubMed
    Summary

    This study evaluated a specialized device designed for the long-term delivery of medication directly into the eye. Researchers implanted the system in animal models and monitored them for several years to assess safety and functionality. The device remained clear and caused minimal tissue reaction, indicating its potential for sustained therapeutic use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impairments and prognostic factors for survival in patients with idiopathic pulmonary fibrosis.

    Respiratory medicine·2003
    Same author

    Eight-year trend of new patients at Clinic for Disabled Patients, University Hospital, Faculty of Dentistry, Tokyo Medical and Dental University.

    Journal of medical and dental sciences·2002
    Same author

    Stress relief as the driving force for self-assembled bi nanolines.

    Physical review letters·2002
    Same author

    Initial experience of percutaneous renal cryosurgery under the guidance of a horizontal open MRI system.

    Radiation medicine·2002
    Same author

    [Pulmonary infarction caused by the spontaneous migration of the vena caval tumor thrombus of right renal cell carcinoma: a case report].

    Hinyokika kiyo. Acta urologica Japonica·2002
    Same author

    Glycine at the 65th position plays an essential role in ATP-dependent protein folding by Archael group II chaperonin.

    Biochemical and biophysical research communications·2001

    Area of Science:

    • Ophthalmology research involving intravitreal cannula systems
    • Veterinary medicine and ocular pharmacology

    Background:

    No prior work had resolved the challenges associated with maintaining consistent medication levels within the eye over extended durations. Current therapeutic approaches often rely on frequent injections that carry significant patient burden and risks. That uncertainty drove the development of specialized hardware for sustained ocular administration. Prior research has shown that traditional delivery methods frequently fail to achieve stable drug concentrations. This gap motivated the creation of a permanent access port for the vitreous chamber. Investigators sought to determine if such a device could remain functional without causing chronic inflammation. No existing literature had fully characterized the long-term biological response to these implanted conduits. This study addresses the need for reliable, chronic access to the posterior segment of the eye.

    Purpose Of The Study:

    The aim of this study was to evaluate the safety and long-term functionality of a novel ocular delivery system. Researchers sought to determine if a permanent conduit could provide reliable access to the vitreous. This gap motivated the investigation into whether such hardware causes chronic irritation or tissue damage. The team focused on assessing the biological response of the eye to the implanted material. They also aimed to verify that the internal channel remains open over several years. This study addresses the need for improved methods in chronic ocular therapy. Investigators hypothesized that a stable, well-tolerated device would facilitate better experimental drug administration. The work provides essential data on the performance of this specific cannula design in animal models.

    Keywords:
    ocular drug deliveryvitreous chamberimplantable devicelong-term follow-up

    Frequently Asked Questions

    The researchers propose that the device enables sustained medication administration by maintaining a clear, patent pathway into the vitreous. They confirmed this functionality by observing the flow of sodium fluorescein through the implanted conduit.

    The team utilized a specialized cannula designed for chronic access. This hardware allows for repeated or continuous therapeutic introduction directly into the eye, bypassing the need for frequent needle punctures.

    The authors suggest that the posterior pole, including the optic nerve, retina, and choroid, remained healthy. This anatomical integrity is necessary to confirm that the device does not cause toxic or mechanical damage to sensitive ocular structures.

    The researchers employed light and electron microscopy to examine the tissue response. These imaging modalities provided high-resolution data on the extent of scar formation at the wound site.

    Related Experiment Videos

    Main Methods:

    Review approach involved a longitudinal assessment of an implanted ocular device in animal subjects. The team selected two rabbits and one primate for the surgical intervention. Investigators monitored the subjects for periods ranging from two and one-half to three years. They performed regular clinical examinations to detect any signs of ocular distress or inflammation. The researchers utilized sodium fluorescein to verify the internal passage remained clear. Post-mortem analysis included detailed histopathological evaluation of the eye tissues. Experts applied light microscopy to inspect the wound site and surrounding structures. Finally, they used electron microscopy to assess cellular changes near the implant site.

    Main Results:

    Key findings from the literature indicate that the device remained functional for up to three years in rabbits. The primate model showed successful device maintenance for two and one-half years. Clinical observations revealed no adverse physiological reactions to the implanted hardware. Histopathological examination showed that scar tissue formation was minimal and restricted to the immediate wound area. The optic nerve, retina, and choroid displayed no signs of structural abnormality. Sodium fluorescein testing confirmed the conduit remained patent throughout the entire follow-up duration. These results suggest the system provides a stable platform for chronic administration. The data indicate that the device is well-tolerated by the ocular environment over long periods.

    Conclusions:

    The authors propose that this hardware supports sustained therapeutic administration within the vitreous chamber. Synthesis and implications suggest the device maintains functionality over multi-year periods in these models. Researchers observed no negative clinical outcomes following the surgical placement of the conduit. Minimal localized fibrosis indicates that the surrounding ocular tissues tolerate the material well. The study demonstrates that the internal pathway remains open for fluid passage throughout the follow-up duration. Histological analysis confirms that the posterior segment structures remain healthy after prolonged device presence. These findings support the potential for using this system in future long-term experimental ocular studies. The authors conclude that the design offers a viable approach for chronic drug delivery needs.

    The investigators measured the patency of the conduit using sodium fluorescein. This dye-based test confirmed that the internal channel remained open and functional throughout the multi-year observation period.

    The authors suggest that this system can be used for repeated or continuous drug delivery in experimental models. They propose that the device is suitable for long-term applications based on the observed lack of adverse effects.